查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1159258

心臟標記的全球市場(2022年～2028年)

Cardiac Marker Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

全球心臟標記的市場規模在預測期間內預計將以8.9％的年複合成長率擴大。越來越多的人患有高血壓、血脂異常和糖尿病等健康問題，這是推動心臟標記物市場增長的因素。

本報告提供全球心臟標記市場相關調查，提供市場概要，以及各類型，各用途，檢查別，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

第3章 競爭情形

  • Roche Diagnostics Ltd.
  • Abbott laboratories
  • Siemens Healthineers AG
  • Danaher Corp
  • Bio merieux SA
  • 主要策略分析
  • COVID-19對主要加入企業帶來的影響

第4章 市場區隔

  • 全球心臟標記市場，各類型
    • 肌酸激梅(CK-MB)
    • 肌鈣蛋白(T,I)
    • 肌紅蛋白
    • 缺血修飾白蛋白
    • 其他
  • 全球心臟標記市場，各用途
    • 心肌梗塞
    • 充血性心臟衰竭
    • 急性冠狀動脈症候群
    • 動脈粥狀硬化性心血管疾病
  • 全球心臟標記市場，檢查別
    • 在檢驗室的檢驗
    • 就地檢驗

第5章 地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 企業簡介

  • LSI Medience Corporation
  • Ortho Clinical Diagnostics
  • Randox laboratories Ltd.
  • Guangzhou Wondfo Biotech Co.,Ltd
  • Diasorin S.p.A
  • Becton, Dickinson and Company
  • Bio-Rad laboratories, Inc.
  • Perkin Elmer Inc.
  • Thermo fisher scientific Inc.
  • Tosoh corporation
  • BG Medicine
  • Dia Dexus Biotechnology Co
  • Trinity Biotech
  • Thermo Fisher Scientific
  • HyTest Ltd.
Product Code: OMR2026363

Global Cardiac Marker Market Size, Share & Trends Analysis Report By Type (Creatine Kinase, Troponins, Myoglobin, Ischemia Modified Albumin, And Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, And Others), And By Location Of Testing (Laboratory Testing And Point Of Care Testing) Forecast 2022-2028

The global Cardiac Marker Market is anticipated to grow at a CAGR of 8.9% globally during the period which is taken for study. According to Food and Drug Administration is US, people who are more in weight as compared to their body mass index, were at 32% higher risk of getting infected by coronary artery disease. People who are affected by obesity when compared with people who have a normal body mass index are at a risk of 81% of getting infected by coronary artery disease. Another driver for the cardiac marker market is people globally suffering from health issues like hypertension, dyslipidemia, diabetes which further cause other health issues. Technological advancements are however making this market more flexible, and more growth can be seen with respect to testing. For instance, in May 2020, Sagentia medical, which is a research organization in the UK said that companies are working to improve the sensitivity of devices so that testing can be done on smaller samples. Abbott's i-state 1 cartridge is capable of testing cardiac markers, chemical proportion, and many other tests on one cartridge.

The global cardiac marker market is segmented based on type, application, and testing. Based on type, the market is segmented into creatine kinase, troponins, myoglobin, ischemia modified albumin, and others. Based on the application, the market is sub-segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Based on testing, the market is sub-segmented laboratory testing and point of care testing. When we go through the segments as per the application, the acute coronary syndrome is anticipated to grow at a prominent rate in the forecasted period. This segment will see a rise as the major population is suffering from obesity and overweight issues which is the major reason for coronary syndrome. For instance, in June 2021, diagnostic company Angel medical system Inc. announced the approval of the FDA on the angel med guardian device.

Geographically market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific is going to be a prominent market for cardiac marker as with changing times, healthcare facilities in these regions are transforming rapidly. The medical sector is experiencing a continuous change through clinical laboratory technology. For instance, in Sept 2021, Biopharmaceutical company AstraZeneca has announced tying up with imperial college London startup VaxEquity to research on its Vaccine which was prepared for Coronavirus, as to how it can work on Heart disease.

The major companies serving the global cardiac marker market include Roche Diagnostics Ltd., Abbott Laboratories, Siemens Healthineers AG, Danaher Corp., Bio Merieux SA, and others. Market players are working consistently and joining hands to work in the area of cardiology. For instance, in Dec 2020, two of the prominent players in the health sector and pharmaceuticals, BridgeBio Pharma and Maze therapeutics have established a joint venture which will focus on manufacturing advanced medicines for cardiovascular disease.

 

Research Methodology

The market study of the global cardiac marker market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Cardiac marker Market Research and Analysis by Type.

2. Global Cardiac marker Market Research and Analysis by Application.

3. Global Cardiac marker Market Research and Analysis by Testing.

The Report Covers:

  • Comprehensive Research Methodology of the global cardiac marker market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Adaptogen Market.
  • Insights about market determinants that are stimulating the global cardiac marker market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on The Global Cardiac marker Market
  • Recovery Scenario of Global Cardiac marker Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Roche Diagnostics Ltd.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Abbott laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Siemens Healthineers AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Danaher Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Bio merieux SA
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Cardiac markers Market by Type
    • 4.1.1. Creatine Kinase (CK-MB)
    • 4.1.2. Troponins (T,I)
    • 4.1.3. Myoglobin
    • 4.1.4. Ischemia Modified Albumin
    • 4.1.5. Others
  • 4.2. Global Cardiac markers Market by Application
    • 4.2.1. Myocardial Infarction
    • 4.2.2. Congestive heart failure
    • 4.2.3. Acute coronary syndrome
    • 4.2.4. Atherosclerosis
  • 4.3. Global Cardiac markers Market by Testing
    • 4.3.1. Laboratory testing
    • 4.3.2. Point of care testing

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. LSI Medience Corporation
  • 6.2. Ortho Clinical Diagnostics
  • 6.3. Randox laboratories Ltd.
  • 6.4. Guangzhou Wondfo Biotech Co.,Ltd
  • 6.5. Diasorin S.p.A
  • 6.6. Becton, Dickinson and Company
  • 6.7. Bio-Rad laboratories, Inc.
  • 6.8. Perkin Elmer Inc.
  • 6.9. Thermo fisher scientific Inc.
  • 6.10. Tosoh corporation
  • 6.11. BG Medicine
  • 6.12. Dia Dexus Biotechnology Co
  • 6.13. Trinity Biotech
  • 6.14. Thermo Fisher Scientific
  • 6.15. HyTest Ltd.

LIST OF TABLES

  • 1. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL CREATINE KINASE CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL TROPONINS CARDIAC MARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL MYOGLOBIN CARDIAC MARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL ISCHEMIA MODIFIED ALBUMIN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL OTHER CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 8. GLOBAL MYOCARDIAL INFARCTION CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL CONGESTIVE HEART FAILURE CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL ACUTE CORONARY SYNDROME CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL ATHEROSCLEROSIS CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL OTHER CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 14. GLOBAL LABORATORY TESTING CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL POINT OF CARE TESTING MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 20. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 21. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 24. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 25. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS TYPE, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 28. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 29. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL CARDIAC MARKER MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL CARDIAC MARKER MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL CARDIAC MARKER MARKET, 2021-2027 (%)
  • 4. GLOBAL CARDIAC MARKER MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL CREATINE KINASE CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL TROPONINS CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL MYOGLOBIN CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL ISCHEMIA MODIFIED ALBUMIN CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL OTHER CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL CARDIAC MARKER MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 11. GLOBAL MYOCARDIAL INFARCTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL CONGESTIVE HEART FAILURE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL CORONARY SYNDROME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL ATHEROSCLEROSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL CARDIAC MARKER MARKET SHARE BY LOCATION OF TESTING, 2021 VS 2028 (%)
  • 17. GLOBAL LABORATORY TESTING CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. GLOBAL POINT OF CARE TESTING CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. GLOBAL CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. US CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. CANADA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. UK CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. FRANCE CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. GERMANY CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. ITALY CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SPAIN CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF EUROPE CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. INDIA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. CHINA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. JAPAN CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. SOUTH KOREA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)